Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 2Active not recruiting 2Withdrawn 1Recruiting 1Completed 1

Sponsor Class

OTHER 1NETWORK 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Gynecologic 2

Conditions

Breast Neoplasms 5Neoplasms 4Ovarian Neoplasms 2Motor Activity 2Fallopian Tube Neoplasms 2Uncertainty 1Polyps 1Pancreatic Neoplasms 1Palliative Care 1Pain 1Obesity 1Neoplasm Metastasis 1Lung Neoplasms 1Knee Tumor 1Inflammation 1Head and Neck Neoplasms 1Depression 1Critical Illness 1Colorectal Neoplasms 1Colonic Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Brenner Tumor 1Breast Carcinoma In Situ 1Breast Cancer Lymphedema 1Adenoma 1

Interventions

Paclitaxel 35Carboplatin 35Bevacizumab 13olaparib 12niraparib 11apatinib 11Gemcitabine 10liposomal doxorubicin 9Hyperthermic Intraperitoneal Chemotherapy 9Cisplatin 9pembrolizumab 8Cyclophosphamide 8fludarabine 7Etoposide 7Topotecan 6Surveys and Questionnaires 5Drug Therapy 5Albumin-Bound Paclitaxel 5fluzoparib 4anlotinib 4Immunohistochemistry 4Ifosfamide 4Doxorubicin 4Docetaxel 4Cytoreduction Surgical Procedures 4Taxes 3Surgical Procedures, Operative 3Poly(ADP-ribose) Polymerase Inhibitors 3Neoadjuvant Therapy 3Laparoscopy 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Ovarian Neoplasms × Methods × Clear all
NCT05410015 2022-06-08

Evaluation of Prognostic Monitoring for Women Who Have Completed Standard Treatment for Ovarian Cancer

Peking Union Medical College Hospital

Unknown
300 enrolled
Gynecologic

Ovarian Neoplasms

NCT00958698 2019-03-12

Symptom Management in Patients With Recurrent or Persistent Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

GOG Foundation

Phase NA Unknown
485 enrolled
Gynecologic

Fallopian Tube Neoplasms, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡